Literature DB >> 10037056

Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature.

K Tsukasaki1, T Maeda, K Arimura, J Taguchi, T Fukushima, Y Miyazaki, Y Moriuchi, K Kuriyama, Y Yamada, M Tomonaga.   

Abstract

A limited number of patients with adult T cell leukemia/lymphoma (ATL) who received autologous stem cell transplantation (ASCT) have been reported. We report here a case of fatal systemic Candida krusei infection in a female patient with ATL undergoing ASCT. All of the eight patients (including seven patients in the literature) with ATL who received ASCT developed relapse of ATL or death due to ASCT complication, irrespective of subtype or remission state of ATL, source or selection of SCT or conditioning regimen. At present, ASCT appears to provide little benefit for ATL in contrast to that for other types of aggressive non-Hodgkin's lymphoma.

Entities:  

Mesh:

Year:  1999        PMID: 10037056     DOI: 10.1038/sj.bmt.1701533

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  22 in total

Review 1.  Hemopoietic stem cell transplantation in T-cell malignancies: who, when, and how?

Authors:  Francesco d'Amore; Esa Jantunen; Thomas Relander
Journal:  Curr Hematol Malig Rep       Date:  2009-10       Impact factor: 3.952

2.  Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWP.

Authors:  A Bazarbachi; K Cwynarski; A Boumendil; H Finel; P Fields; K Raj; A Nagler; M Mohty; A Sureda; P Dreger; O Hermine
Journal:  Bone Marrow Transplant       Date:  2014-07-14       Impact factor: 5.483

3.  Early spatial and temporal events of human T-lymphotropic virus type 1 spread following blood-borne transmission in a rabbit model of infection.

Authors:  Rashade A H Haynes; Bevin Zimmerman; Laurie Millward; Evan Ware; Christopher Premanandan; Lianbo Yu; Andrew J Phipps; Michael D Lairmore
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

Review 4.  Human T cell lymphotropic virus-associated leukemia/lymphoma.

Authors:  Lee Ratner
Journal:  Curr Opin Oncol       Date:  2005-09       Impact factor: 3.645

Review 5.  Allogeneic stem cell transplantation for adult T-cell leukemia/lymphoma.

Authors:  Jun Okamura; Naokuni Uike; Atae Utsunomiya; Ryuji Tanosaki
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

6.  Cyclosporine-induced immune suppression alters establishment of HTLV-1 infection in a rabbit model.

Authors:  Rashade A H Haynes; Evan Ware; Christopher Premanandan; Bevin Zimmerman; Lianbo Yu; Andrew J Phipps; Michael D Lairmore
Journal:  Blood       Date:  2009-11-20       Impact factor: 22.113

Review 7.  Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?

Authors:  E H Phillips; A Hodson; O Hermine; A Bazarbachi; K Cwynarski
Journal:  Bone Marrow Transplant       Date:  2016-09-12       Impact factor: 5.483

8.  Treatment of peripheral T-cell lymphoma: are we data driven or driving the data?

Authors:  Matthew A Lunning; Steven Horwitz
Journal:  Curr Treat Options Oncol       Date:  2013-06

9.  Establishment of hybridomas producing cancer specific human antibodies from B cell line derived from PBL of a patient with adult T cell leukemia.

Authors:  T Kawahara; A Ichikawa; Y Katakura; K Teruya; T Yoshida; M Kikuchi; M Kamei; S Hashizume; S Shirahata
Journal:  Cytotechnology       Date:  2001-07       Impact factor: 2.058

10.  Animal models on HTLV-1 and related viruses: what did we learn?

Authors:  Hiba El Hajj; Rihab Nasr; Youmna Kfoury; Zeina Dassouki; Roudaina Nasser; Ghada Kchour; Olivier Hermine; Hugues de Thé; Ali Bazarbachi
Journal:  Front Microbiol       Date:  2012-09-21       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.